Genevant Sciences
Private company1 field
Where it works
| Technology | ||
|---|---|---|
| NanotechnologyLicenses LNP and ligand conjugate platforms for delivering nucleic acid drugs. | Licenses LNP and ligand conjugate platforms for delivering nucleic acid drugs. | genevant.com |
About
- Source
- genevant.com (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Sep 25, 2026
| Date | Change | ||
|---|---|---|---|
| Sep 25, 2026 | Genevant SciencesCompany in Nanotechnology: Joined a field, Licenses LNP and ligand conjugate platforms for delivering nucleic acid drugs. | seed | genevant.com |
| Sep 25, 2026 | Genevant SciencesCompany: Added | seed | genevant.com |